Corrigendum to “Real-world long-term continuation of lecanemab therapy and the clinical utility of phosphorylated tau 181” [The Journal of Prevention of Alzheimer's Disease (2026) 100664]
- DOI
- 10.1016/j.tjpad.2026.100668
- Published
- 2026-11
- Container
- The Journal of Prevention of Alzheimer's Disease
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.tjpad.2026.100668,
title = {Corrigendum to “Real-world long-term continuation of lecanemab therapy and the clinical utility of phosphorylated tau 181” [The Journal of Prevention of Alzheimer's Disease (2026) 100664]},
author = {Moeko Noguchi-Shinohara and Daiki Muramatsu and Ayano Shima and Yasuhiro Sakashita and Yasutake Tada and Hiroki Yamaguchi and Junji Komatsu and Tokuhei Ikeda and Kenjiro Ono},
year = {2026},
journal = {The Journal of Prevention of Alzheimer's Disease},
doi = {10.1016/j.tjpad.2026.100668},
url = {https://doi.org/10.1016/j.tjpad.2026.100668}
}RIS
TY - JOUR TI - Corrigendum to “Real-world long-term continuation of lecanemab therapy and the clinical utility of phosphorylated tau 181” [The Journal of Prevention of Alzheimer's Disease (2026) 100664] AU - Moeko Noguchi-Shinohara AU - Daiki Muramatsu AU - Ayano Shima AU - Yasuhiro Sakashita AU - Yasutake Tada AU - Hiroki Yamaguchi AU - Junji Komatsu AU - Tokuhei Ikeda AU - Kenjiro Ono PY - 2026 JO - The Journal of Prevention of Alzheimer's Disease DO - 10.1016/j.tjpad.2026.100668 UR - https://doi.org/10.1016/j.tjpad.2026.100668 ER -
APA
Noguchi-Shinohara, M., Muramatsu, D., Shima, A., Sakashita, Y., Tada, Y., Yamaguchi, H., Komatsu, J., Ikeda, T., & Ono, K. (2026). Corrigendum to “Real-world long-term continuation of lecanemab therapy and the clinical utility of phosphorylated tau 181” [The Journal of Prevention of Alzheimer's Disease (2026) 100664]. The Journal of Prevention of Alzheimer's Disease. https://doi.org/10.1016/j.tjpad.2026.100668
Source records
- crossref · retrieved 2026-09-25T15:16:09.976Z